FDA expands Repatha indication to adults at risk of major cardiovascular events from uncontrolled LDL-C
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Strokes are affecting approximately 1.8 million people annually
CSPC will receive an upfront payment of $100 million from AstraZeneca
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Dyslipidemia is a critical risk factor for cardiovascular diseases
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Subscribe To Our Newsletter & Stay Updated